NewYork-Presbyterian plans new cancer center

NewYork-Presbyterian plans to build a nearly 400,000-square-foot cancer center at its Columbia University Irving Medical Center in New York City’s Washington Heights neighborhood.

Advertisement

According to documents NewYork-Presbyterian submitted to the city’s zoning application portal Feb. 8, the proposed building would consolidate cancer care facilities that are currently spread across different facilities on the medical campus. It would include space for diagnostic services, treatment and ambulatory surgery. It would also enable the medical center to expand cancer research and clinical trials. The plannng documents did not include cost estimates. 

“The proposed center will be a new hub for innovative outpatient cancer care and other clinical services, as well as dynamic research, all designed to address the clinical needs of the communities we serve in Northern Manhattan and beyond,” NewYork-Presbyterian said in a statement to Becker’s. “We are working with the community, elected officials and the Department of Health as the planning process continues. We look forward to sharing additional details about this important project over the coming months.”

NewYork-Presbyterian/Columbia University Medical Center includes the Herbert Irving Comprehensive Cancer Center.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.